Chitosan Nanoparticles Act as an Adjuvant to Promote both Th1 and Th2 Immune Responses Induced by Ovalbumin in Mice
2011

Chitosan Nanoparticles Enhance Immune Responses in Mice

Sample size: 36 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wen Zheng-Shun, Xu Ying-Lei, Zou Xiao-Ting, Xu Zi-Rong

Primary Institution: Key Laboratory for Molecular Animal Nutrition of Ministry of Education, Feed Science Institute, College of Animal Science, Zhejiang University

Hypothesis

Chitosan nanoparticles (CNP) may have the adjuvant potential to amplify immune response against vaccination by stimulating the innate immune system.

Conclusion

Chitosan nanoparticles significantly enhance both cellular and humoral immune responses to ovalbumin in mice without causing toxicity.

Supporting Evidence

  • CNP significantly enhanced OVA-specific antibody levels compared to control groups.
  • CNP improved natural killer cell activity in OVA-immunized mice.
  • CNP increased splenocyte proliferation in response to various stimuli.
  • CNP elevated levels of Th1 and Th2 cytokines in splenocytes from immunized mice.
  • CNP up-regulated mRNA expression of key cytokines in splenocytes.

Takeaway

Chitosan nanoparticles help the body fight infections better by boosting the immune system when given with a vaccine.

Methodology

ICR mice were immunized with ovalbumin alone or with chitosan nanoparticles, and various immune responses were measured.

Limitations

The study primarily focused on a single model antigen and may not generalize to all vaccines.

Participant Demographics

Five-week-old female ICR mice, weighing 18–22 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/md9061038

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication